Mouse models in preclinical studies for pachyonychia congenita

被引:12
作者
Chen, J
Roop, DR
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA
关键词
gene therapy; inducible mouse model; inherited epidermal disease; keratin; keratin intermediate filament; K6a; pachyonychia congenita; skin;
D O I
10.1111/j.1087-0024.2005.10206.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The similarities between the human and mouse genomes often allow researchers to make accurate predictions about the roles of their human counterparts. Because of the similar physiology between these two mammals, mice are used extensively in the laboratory to investigate the mechanisms of human diseases. Furthermore, mice provide us with the option of testing the toxicity of drugs and the safety of therapeutic approaches prior to human application. Here, we review the existing mouse models involving the keratin genes (K6a, K6b, K16, and K17) that cause the human genetic disorder pachyonychia congenita (PC). We also suggest methods to more accurately model this autosomal dominant skin condition in the mouse in order to better understand the pathophysiological processes underlying PC and importantly, provide a test-bed for testing emerging therapies in vivo.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 18 条
[1]   Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders [J].
Arin, MJ ;
Longley, MA ;
Wang, XJ ;
Roop, DR .
JOURNAL OF CELL BIOLOGY, 2001, 152 (03) :645-649
[2]  
Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO
[3]  
2-#
[4]   An inducible mouse model for epidermolysis bullosa simplex: Implications for gene therapy [J].
Cao, TY ;
Longley, MA ;
Wang, XJ ;
Roop, DR .
JOURNAL OF CELL BIOLOGY, 2001, 152 (03) :651-656
[5]   Regulation of cre recombinase activity by the synthetic steroid RU 486 [J].
Kellendonk, C ;
Tronche, F ;
Monaghan, AP ;
Angrand, PO ;
Stewart, F ;
Schutz, G .
NUCLEIC ACIDS RESEARCH, 1996, 24 (08) :1404-1411
[6]   Keratins and skin disorders [J].
Lane, EB ;
McLean, WHI .
JOURNAL OF PATHOLOGY, 2004, 204 (04) :355-366
[7]   Clinical and pathological features of pachyonychia congenita [J].
Leachman, SA ;
Kaspar, RL ;
Fleckman, P ;
Florell, SR ;
Smith, FJD ;
McLean, WHI ;
Lunny, DP ;
Milstone, LM ;
van Steensel, AM ;
Munro, CS ;
O'Toole, EA ;
Celebi, JT ;
Kansky, A ;
Lane, EB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2005, 10 (01) :3-17
[8]   Gene therapy for autosomal dominant disorders of keratin [J].
Lewin, AS ;
Glazer, PM ;
Milstone, LM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2005, 10 (01) :47-61
[9]   Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot [J].
Lin, MTS ;
Levy, ML ;
Bowden, PE ;
Magro, C ;
Baden, L ;
Baden, HP ;
Roop, DR .
EXPERIMENTAL DERMATOLOGY, 1999, 8 (02) :115-119
[10]   Keratin 17 null mice exhibit age- and strain-dependent alopecia [J].
McGowan, KM ;
Tong, XM ;
Colucci-Guyon, E ;
Langa, F ;
Babinet, C ;
Coulombe, PA .
GENES & DEVELOPMENT, 2002, 16 (11) :1412-1422